Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.1092 +0.0032 (+3.02%)
Streaming Delayed Price Updated: 12:25 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
(APLT) - Analyzing Applied Therapeutics's Short Interest ↗
 
Via Benzinga
News headline image
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Applied Therapeutics, Inc. 
Via Benzinga
News headline image
Applied Therapeutics: Q3 Earnings Insights ↗
 
Via Benzinga
Applied Therapeutics Inc. (NASDAQ: APLT) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Turns Lower; ISM Services PMI Falls In December ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Applied Therapeutics' Diabetes-Associated Heart Disease Drug Fails In Phase 3 Study, Stock Plunges ↗
Applied Therapeutics Inc (NASDAQ: APLT) released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of  
Via Benzinga
News headline image
Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts ↗
Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs. 
Via InvestorPlace
Topics Workforce
News headline image
US Stocks Higher; Payrolls Increase By 216,000 In December ↗
U.S. stocks traded higher this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40.... 
Via Benzinga
Topics Stocks
News headline image
Why Is Safe and Green Development (SGD) Stock Up 50% Today? ↗
Safe and Green Development stock is up on Friday as investors in SGD celebrate the company's plans to acquire Majestic World Holdings. 
Via InvestorPlace
News headline image
Why Is Applied Therapeutics (APLT) Stock Down 30% Today? ↗
Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of... 
Via Benzinga
Topics Intellectual Property
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! 
Via InvestorPlace
News headline image
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
From Applied Therapeutics
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Applied Therapeutics Reports Third Quarter 2023 Financial Results
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics to Present at the UBS Biopharma Conference 2023
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Reports Second Quarter 2023 Financial Results
From Applied Therapeutics
Via GlobeNewswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.